Joanna Strober observes that CEOs face constant pressure from investors to hit forward-looking financial targets, which tempts them to focus excessively on long-term expansion. Healthy product teams do not simply yield to visionary executives. Instead, they act as an essential counterbalance by highlighting current operational breakdowns and pushing back on promises that cannot realistically be delivered.
Midi initially focused its trust-building efforts almost entirely on the clinician visit itself, only to realize that trust degrades if onboarding, lab reminders, and referral follow-ups are neglected. Relying on individual clinician charisma also introduces platform risk if providers depart. Digital health companies must purposefully embed operational reliability and communication into the brand experience outside the consultation room.
Because generic treatments like estrogen and testosterone lack commercial patent incentives, they often lack decades of clinical trials. Instead of projecting false certainty, Midi builds patient trust through transparent, shared decision-making. By directly explaining what the science supports, what remains unknown, and what is clinically safe, providers empower patients to participate actively in choosing their care plan.
To deliver complex women's healthcare at scale without hiring an army of expensive doctors, Midi pairs nurse practitioners with a three-layer knowledge stack: AI inputs, standardized searchable protocols written by specialists, and real-time Slack rooms staffed daily by on-call physicians. This hybrid workflow allows mid-level clinicians to resolve complex specialist questions safely while maintaining high visit throughput.
Foundation models like OpenAI prioritize historical, large-scale literature over newer, smaller medical studies. In under-researched domains such as hormone therapy and female testosterone use, this training hierarchy leads to outdated or inaccurate guidance. Relying on raw consumer LLMs for specialized healthcare can actively harm patients by reinforcing outdated clinical biases rather than reflecting recent clinical findings.
By using AI scribes to audit transcripts comparing high-retention clinicians against those with high 'one-and-done' rates, Midi discovered that repeat bookings rarely correlate with clinical safety or diagnostic accuracy. Instead, churn is determined by communication style: whether the clinician ensures the patient feels heard, provides concrete next steps, and clearly specifies post-visit plans.
Menopause specialists typically adopt high-cost concierge cash models due to high demand and low provider supply. Midi deliberately took the difficult path of securing commercial insurance coverage across all 50 states from inception. This operational choice turned specialized care from an executive luxury into accessible healthcare for shift workers and factory employees who consult clinicians from break rooms and cars.
Many healthcare founders believe that maintaining strict visit lengths or demanding operational efficiency conflicts with their patient care mission. Strober argues that capping consultation times is mandatory to achieve business profitability, which in turn fuels the technology required to deliver affordable care to millions. Efficiency and clinical mission are complementary forces rather than opposing incentives.